Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03691220 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Improving Medication Adherence in Adolescents Who Had a Liver Transplant

Study acronym: iMALT
StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Results posted: Sep 30, 2026 Show 7 more changesShow less
    • Primary endpoint revised
    • Eligibility criteria expanded, about 12 words
    • Secondary endpoints revised (11)
    • Study description revised
    • Site details revised at 9 of 13 sites
    • Collaborators: details revised at 6 of 14 entries
    • Publications: details revised at 3 of 3 entries
  2. Primary and study completion dates: Oct 22, 2024 to Oct 22, 2025v17
  3. Trial status: Active, Not Recruiting to Completed
    • Primary and study completion dates changed from estimate of Dec 2024 to Oct 22, 2024
    v16
  4. Primary and study completion dates: Oct 2024 to Dec 2024v15
  5. Re-verified, no change to tracked fieldsv14
Show 12 earlier versionsHide 12 earlier versions
  1. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 156 to confirmed 148
    • Study sites: 14 to 13
    v13
  2. Primary and study completion dates: Sep 30, 2023 to Oct 2024v12
  3. Study description expanded, about 1 wordv11
  4. Study sites: 13 to 14
    • Collaborators: 13 to 14
    v10
  5. Collaborators: 12 to 13v9
  6. Study sites: 12 to 13v8
  7. Eligibility criteria revisedv7
  8. Study sites: 11 to 12
    • Collaborators: 11 to 12
    v6
  9. Site details revised at 4 of 11 sitesv5
  10. Site details revised at 4 of 11 sitesv4
  11. Start date changed from estimate of Oct 31, 2018 to Nov 14, 2018
    • Site details revised at 2 of 11 sites
    v3
  12. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Oct 1, 2018 to Oct 31, 2018
    • Study sites: 10 to 11
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study's aim is to test a tailored telemetric intervention to reduce rejection incidence by improving medication adherence in a group of adolescent liver transplant recipients identified as nonadherent by a marker (the Medication Level Variability Index, MLVI).
Trial Details
NCT Number NCT03691220
Lead Sponsor Icahn School of Medicine at Mount Sinai
Collaborators: University of California, Los Angeles, Ann & Robert H Lurie Children's Hospital of Chicago, Baylor College of Medicine, University of Pittsburgh, University of California, San Francisco, Children's Hospital of Michigan, Children's Hospital of Philadelphia, Emory-Children's Center, The Hospital for Sick Children, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Columbia University, Seattle Children's Hospital, University of Miami, Children's Hospital Los Angeles
Conditions
(from sponsor)		 Transplant
Enrollment 148 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov